← Leaderboards
Kelly S. Barth
Medical University Of South Carolina
$8,372,333
Attributed
$15,957,713
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,957,713 · 3
By mechanism
UG1$11,880,136 · 1
R01$3,290,624 · 1
K23$786,953 · 1
Top collaborators
- Kathleen Theresa Brady12 shared
- Jeffrey J Borckardt1 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Kathleen Theresa Brady$137,017,915
- Jeffrey J Borckardt$7,784,421
- Bashar W Badran$2,026,016
- Sara Michelle Witcraft$182,249
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsAreaInnovationMultidisciplinaryNational Institute Of Drug AbuseAddictionMissionOpioidFundingImplementation ScienceProtocols DocumentationResearch PersonnelClinical TrialsHealth Care SettingsCollaborationsClinical ResearchClinical Trials NetworkCreativenessFlexibilityData AnalyticsLeadershipConduct Clinical TrialsCommunitiesHealth Technology
Grant awards (17)
Southern Consortium Node of the Clinical Trials Network (Varenicline)$786,557
UG1 · FY2025 · DA · contact PI
Southern Consortium Node of the Clinical Trials Network$755,000
UG1 · FY2025 · DA · contact PI
Southern Consortium Node of the Clinical Trials Network (TMS for CUD)$243,871
UG1 · FY2025 · DA · contact PI
Southern Consortium Node of the Clinical Trials Network$746,759
UG1 · FY2024 · DA
Sequential Trial of Adding Buprenorphine, Cognitive Behavioral Treatment, and Transcranial Magnetic Stimulation to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain (ACTION)$3,290,624
R01 · FY2023 · DA · contact PI
Southern Consortium Node of the Clinical Trials Network$934,736
UG1 · FY2023 · DA
Southern Consortium Node of the Clinical Trials Network$1,761,373
UG1 · FY2022 · DA
Southern Consortium Node of the Clinical Trials Network$405,432
UG1 · FY2022 · DA
Patients decline buprenorphine from the emergency department CTN:0107 add on$275,820
UG1 · FY2022 · DA
Southern Consortium Node of the Clinical Trials Network$2,018,570
UG1 · FY2021 · DA
Southern Consortium Node of the Clinical Trials Network$1,651,467
UG1 · FY2021 · DA
Southern Consortium Node of the Clinical Trials Network$1,754,634
UG1 · FY2020 · DA
Southern Consortium Node of the Clinical Trials Network$545,917
UG1 · FY2020 · DA
Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper$200,772
K23 · FY2019 · DA · contact PI
Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper$200,772
K23 · FY2018 · DA · contact PI
Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper$200,772
K23 · FY2017 · DA · contact PI
Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper$184,637
K23 · FY2016 · DA · contact PI